David Pauza

Bio

David Pauza, PhD is Professor of Medicine at the University of Maryland Medical School in Baltimore. Dr. Pauza earlier served as Associate Director for the university’s prestigious Institute of Human Virology and Co-Leader of the Greenebaum Cancer Center Program in Viral Oncology. David Pauza is an innovator in viral immunology, treatment and prevention. He has a deep background in human immunology of infectious diseases and specialized areas of tumor immunology. Accomplished in product design and development using viral vector technology. He has made a number of viral vector innovations and created innovative strategies for clinical application of viral vector technology and genetic medicines. Dr. Pauza was honored as the United Nations Scientific, Cultural and Educational Organization’s Visiting Professor in Biotechnology at the University of Rome and the William J. Way Visiting Professor at the Duke University Center for AIDS Research. Dr. Pauza received the Chernow Foundation Award from the American Foundation for AIDS Research and is Honorary Member of the Gold Key Society. David Pauza has been funded continuously by the N.I.H. for nearly 30 years. Dr. Pauza is recognized for his outstanding efforts as a scientific thought leader, educator and consultant. He was an empaneled member of the Vaccine Study Section for the N.I.H. and has been active as a reviewer of federal grants and programs. He has been and continues on the editorial boards of several scientific journals, has consulted for a number of small to medium biotechnology companies and been an advisor to numerous health advocacy organizations including the AIDSResearch Alliance. Dr. Pauza received his PhD in 1981 from the Department of Molecular Biology, University of California Berkeley in the laboratory of Howard K. Schachman, PhD and had postdoctoral training at the Laboratory of Molecular Biology, Cambridge, England under Sydney Brenner, MD. In 1985 he started the HIV/AIDS research program at the Salk Institute for Biological Studies in La Jolla, California then moved to the University of Wisconsin-Madison in 1990 to build a diverse program on HIV/AIDS there. In 2000 he was recruited to the Institute of Human Virology in Baltimore, Maryland before joining AGT as a consultant (2012) and subsequently as Chief Science Officer (2015). He has published more than 150 scientific papers and holds 3 US patents.